Verrica Pharmaceuticals Financial Overview
Verrica Pharmaceuticals's market cap is currently $74.21M. The company's EPS TTM is $-0.03; its P/E ratio is -2.27; Verrica Pharmaceuticals is scheduled to report earnings on November 14, 2025, and the estimated EPS forecast is $-0.81. See an overview of income statement, balance sheet, and cash flow financials.
